MUFG Securities Americas’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$597K Buy
3,044
+47
+2% +$9.13K 0.04% 358
2025
Q4
$520K Sell
2,997
-19
-0.6% -$3.46K 0.03% 387
2025
Q3
$575K Buy
3,016
+542
+22% +$96.2K 0.04% 364
2025
Q2
$444K Buy
2,474
+509
+26% +$88.4K 0.04% 367
2025
Q1
$332K Buy
1,965
+317
+19% +$52.1K 0.04% 371
2024
Q4
$249K Buy
+1,648
New +$256K 0.03% 399

Other funds holding DGX

MUFG Securities Americas's DGX Position: Q1 2026 in Review

MUFG Securities Americas increased its Quest Diagnostics (DGX) stake by 1.6% in Q1 2026, buying an estimated $9.13K and bringing the position to 3,044 shares worth $597K. The position accounts for 0.04% of the portfolio, ranked #358.

MUFG Securities Americas first reported a position in DGX in Q4 2024 and has held it in 6 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • MUFG Securities Americas held 3,044 shares of Quest Diagnostics worth $597K as of Q1 2026.
  • MUFG Securities Americas bought 47 Quest Diagnostics shares in Q1 2026, an estimated $9.13K.
  • Quest Diagnostics made up 0.04% of MUFG Securities Americas's portfolio in Q1 2026, its #358 holding.
  • MUFG Securities Americas first reported a position in Quest Diagnostics in Q4 2024 and has held it in 6 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.